Eaton Vance Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.29M | Buy |
11,658
+233
| +2% | +$45.8K | ﹤0.01% | 1017 |
|
|
2022
Q2 | $2.45M | Sell |
11,425
-831
| -7% | -$178K | ﹤0.01% | 1015 |
|
|
2022
Q1 | $3.48M | Sell |
12,256
-110,390
| -90% | -$31.3M | ﹤0.01% | 995 |
|
|
2021
Q4 | $46.2M | Sell |
122,646
-17,216
| -12% | -$6.49M | 0.06% | 316 |
|
|
2021
Q3 | $57.5M | Buy |
139,862
+15,088
| +12% | +$6.2M | 0.08% | 237 |
|
|
2021
Q2 | $46.2M | Buy |
124,774
+124,521
| +49,218% | +$46.1M | 0.06% | 291 |
|
|
2021
Q1 | $73K | Buy |
+253
| New | +$73K | ﹤0.01% | 1688 |
|
|
2014
Q2 | – | Sell |
-487,691
| Closed | -$29.4M | – | 889 |
|
|
2014
Q1 | $29.4M | Buy |
487,691
+30,538
| +7% | +$1.84M | 0.09% | 184 |
|
|
2013
Q4 | $24.2M | Buy |
457,153
+84,229
| +23% | +$4.47M | 0.07% | 200 |
|
|
2013
Q3 | $17.3M | Buy |
+372,924
| New | +$17.3M | 0.05% | 227 |
|